Embera NeuroTherapeutics Overview
- Year Founded
-
2005
- Status
-
Private
- Employees
-
2
- Latest Deal Type
-
Series A2
- Latest Deal Amount
-
$20K
- Investors
-
15
Embera NeuroTherapeutics General Information
Description
Operator of a pharmaceutical company intended to develop novel treatments to potentially treat a range of addictions. The company's medication reduces the cravings and loss of control that drive addiction by targeting multiple pathways, to maximize potential efficacy more than either drug used alone, enabling patients to abstain from smoking and drug use.
Contact Information
Website
www.emberaneuro.comCorporate Office
- 365 Boston Post Road
- Suite 212
- Sudbury, MA 01776
- United States
Corporate Office
- 365 Boston Post Road
- Suite 212
- Sudbury, MA 01776
- United States
Embera NeuroTherapeutics Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
12. Later Stage VC (Series A2) | 11-Sep-2020 | $20K | Completed | Clinical Trials - Phase 2 | ||
11. Later Stage VC (Series B) | 01-Aug-2020 | Completed | Clinical Trials - Phase 2 | |||
10. Later Stage VC (Series B) | 09-Nov-2016 | Completed | Clinical Trials - Phase 1 | |||
9. Grant | 01-Aug-2016 | Completed | Clinical Trials - Phase 1 | |||
8. Grant | 26-Jul-2016 | Completed | Clinical Trials - Phase 1 | |||
7. Later Stage VC (Series A2) | 29-Sep-2015 | Completed | Clinical Trials - Phase 1 | |||
6. Accelerator/Incubator | 05-Aug-2015 | Completed | Clinical Trials - Phase 1 | |||
5. Grant | 01-Jul-2014 | Completed | Clinical Trials - Phase 1 | |||
4. Later Stage VC (Series A2) | 15-Aug-2011 | $4.5M | $9.5M | Completed | Startup | |
3. Early Stage VC (Series A) | 03-Sep-2008 | $3M | $4.96M | Completed | Startup |
Embera NeuroTherapeutics Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Series B | ||||||||
Series A2 | ||||||||
Series A1 | 1,357,100 | $0.001000 | $0.06 | $1 | $1 | 1x | $1 | 3.74% |
Embera NeuroTherapeutics Comparisons
Industry
Financing
Details
Embera NeuroTherapeutics Competitors (2)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Achaogen | Formerly VC-backed | South San Francisco, CA | ||||
Spero Therapeutics | Formerly VC-backed | Cambridge, MA |
Embera NeuroTherapeutics Patents
Embera NeuroTherapeutics Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20200360400-A1 | Compositions and methods for the treatment of addiction, psychiatric disorders, and neurodegenerative disease | Inactive | 19-May-2017 | ||
EP-3592350-A4 | Pharmaceutical compositions and uses thereof | Pending | 10-Mar-2017 | ||
CA-3055940-A1 | Pharmaceutical compositions and uses thereof | Pending | 10-Mar-2017 | ||
AU-2018230521-B2 | Pharmaceutical compositions and uses thereof | Active | 10-Mar-2017 | ||
US-11179377-B2 | Pharmaceutical compositions and uses thereof | Active | 10-Mar-2017 | A61K9/1611 |
Embera NeuroTherapeutics Signals
Embera NeuroTherapeutics Investors (15)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
Seven Funds | Venture Capital | Minority | ||
Gulf South Angels | Angel Group | Minority | ||
Technomark Life Sciences | Venture Capital | Minority | ||
ROSE RESEARCH CENTER, LLC | Corporation | |||
BRF(Shreveport) | Government | Minority |
Embera NeuroTherapeutics FAQs
-
When was Embera NeuroTherapeutics founded?
Embera NeuroTherapeutics was founded in 2005.
-
Where is Embera NeuroTherapeutics headquartered?
Embera NeuroTherapeutics is headquartered in Sudbury, MA.
-
What is the size of Embera NeuroTherapeutics?
Embera NeuroTherapeutics has 2 total employees.
-
What industry is Embera NeuroTherapeutics in?
Embera NeuroTherapeutics’s primary industry is Drug Discovery.
-
Is Embera NeuroTherapeutics a private or public company?
Embera NeuroTherapeutics is a Private company.
-
What is Embera NeuroTherapeutics’s current revenue?
The current revenue for Embera NeuroTherapeutics is
. -
How much funding has Embera NeuroTherapeutics raised over time?
Embera NeuroTherapeutics has raised $24.5M.
-
Who are Embera NeuroTherapeutics’s investors?
Seven Funds, Gulf South Angels, Technomark Life Sciences, ROSE RESEARCH CENTER, LLC, and BRF(Shreveport) are 5 of 15 investors who have invested in Embera NeuroTherapeutics.
-
Who are Embera NeuroTherapeutics’s competitors?
Achaogen and Spero Therapeutics are competitors of Embera NeuroTherapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »